More on VSTM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.76 |
|
|||
| Open | $3.76 | ||||
| 52 Wk High | $2.43 | ||||
| 52 Wk Low | $1.05 | ||||
| Day High | $4.00 | ||||
| Day Low | $3.67 | ||||
| P/E | N/A | ||||
| EPS | $-1.79 | ||||
| Volume | 1,534,191 | ||||
- Buy this biotech stock now, Mizuho urges
- FDA grants fast track status to Verastem's lung cancer drug VS-7375
- Verastem Oncology Announces U.S. FDA Fast Track Designation for VS-7375, an Oral and Potential Best-in-Class Investigational KRAS G12D (ON/OFF) Inhibitor for the Treatment of KRAS G12D-Mutated Locally
- Form S-8 Verastem, Inc.
- Form 4 Verastem, Inc. For: May 21 Filed by: BAILEY MICHAEL P
- Form 3 Verastem, Inc. For: May 21 Filed by: BAILEY MICHAEL P
- Form 144 Verastem, Inc. Filed by: Gagnon Robert E.
- Verastem Oncology to Present at Jefferies Healthcare Conference
- Form 4 Verastem, Inc. For: May 21 Filed by: Tollefson Karin Anna
- Form 4 Verastem, Inc. For: May 21 Filed by: Stuglik Brian M
Entities mentioned with VSTM
- FDA | View Related Stories »
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Pre Market Movers | View Related Stories »
- Show More...
